ArticleJournal of molecular medicine (Berlin, Germany)2014

The novel fusion protein sTRAIL-TMTP1 exhibits a targeted inhibition of primary tumors and metastases.

Ronghua Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.